When are clinical trials of a given agent vs. placebo no longer appropriate or feasible?
- 31 December 1997
- journal article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 18 (6) , 613-620
- https://doi.org/10.1016/s0197-2456(97)00058-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Mortality Associated With Low Plasma Concentration of Beta Carotene and the Effect of Oral SupplementationJAMA, 1996
- The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiologic and Clinical Trial DataAnnals of Internal Medicine, 1995
- Immediate versus Delayed Fluid Resuscitation for Hypotensive Patients with Penetrating Torso InjuriesNew England Journal of Medicine, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1992
- Do the Results of Randomized Clinical Trials of Cardiovascular Drugs Influence Medical Practice?New England Journal of Medicine, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987